WeSearch

OneSource Q1FY27 slides: semaglutide drives 37% revenue growth

· 0 reactions · 0 comments · 6 views
About this source

Investing.com — News files mainly under finance. We currently carry 7,413 of its stories.

All Investing.com — News coverage →
Original article
Investing.com — News
Read full at Investing.com — News →
Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from Investing.com — News

Yardeni asks: Which Inflation Rate Is Warsh Targeting?
Investing.com — News5 views
ETF assets in Brazil nearly triple in two years to $22.8bn
Investing.com — News6 views
FOMC Preview: Fed likely to hold rates despite oil spike, Citi sees dovish outcome
Investing.com — News5 views
Brazil recalls ambassador to Argentina after Milei attacks Lula, sources say
Investing.com — News7 views
Iran will halt attacks as long as US maintains pause, Iranian source says after Trump calls off strikes
Investing.com — News9 views
Kremlin says too early to comment on reported US-Ukraine air ceasefire talks
Investing.com — News9 views